127 related articles for article (PubMed ID: 20943398)
1. Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors.
Behery FA; Elnagar AY; Akl MR; Wali VB; Abuasal B; Kaddoumi A; Sylvester PW; El Sayed KA
Bioorg Med Chem; 2010 Nov; 18(22):8066-75. PubMed ID: 20943398
[TBL] [Abstract][Full Text] [Related]
2. Optimization of tocotrienols as antiproliferative and antimigratory leads.
Behery FA; Akl MR; Ananthula S; Parajuli P; Sylvester PW; El Sayed KA
Eur J Med Chem; 2013 Jan; 59():329-41. PubMed ID: 23274571
[TBL] [Abstract][Full Text] [Related]
3. Design and preliminary structure-activity relationship of redox-silent semisynthetic tocotrienol analogues as inhibitors for breast cancer proliferation and invasion.
Elnagar AY; Wali VB; Sylvester PW; El Sayed KA
Bioorg Med Chem; 2010 Jan; 18(2):755-68. PubMed ID: 20022507
[TBL] [Abstract][Full Text] [Related]
4. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
5. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
Park SK; Sanders BG; Kline K
Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
[TBL] [Abstract][Full Text] [Related]
6. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells.
McIntyre BS; Briski KP; Gapor A; Sylvester PW
Proc Soc Exp Biol Med; 2000 Sep; 224(4):292-301. PubMed ID: 10964265
[TBL] [Abstract][Full Text] [Related]
8. A redox-silent analogue of tocotrienol acts as a potential cytotoxic agent against human mesothelioma cells.
Kashiwagi K; Virgona N; Harada K; Kido W; Yano Y; Ando A; Hagiwara K; Yano T
Life Sci; 2009 May; 84(19-20):650-6. PubMed ID: 19232361
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
Wali VB; Bachawal SV; Sylvester PW
Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
[TBL] [Abstract][Full Text] [Related]
10. Concurrent delivery of tocotrienols and simvastatin by lipid nanoemulsions potentiates their antitumor activity against human mammary adenocarcenoma cells.
Alayoubi AY; Anderson JF; Satyanarayanajois SD; Sylvester PW; Nazzal S
Eur J Pharm Sci; 2013 Feb; 48(3):385-92. PubMed ID: 23262057
[TBL] [Abstract][Full Text] [Related]
11. Gamma- and delta-tocotrienols exert a more potent anticancer effect than alpha-tocopheryl succinate on breast cancer cell lines irrespective of HER-2/neu expression.
Pierpaoli E; Viola V; Pilolli F; Piroddi M; Galli F; Provinciali M
Life Sci; 2010 Apr; 86(17-18):668-75. PubMed ID: 20188744
[TBL] [Abstract][Full Text] [Related]
12. Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
Foudah AI; Sallam AA; Akl MR; El Sayed KA
Eur J Med Chem; 2014 Feb; 73():310-24. PubMed ID: 24487236
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs.
Gagic Z; Ivkovic B; Srdic-Rajic T; Vucicevic J; Nikolic K; Agbaba D
Eur J Pharm Sci; 2016 Jun; 88():59-69. PubMed ID: 27063330
[TBL] [Abstract][Full Text] [Related]
14. Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells.
Sylvester PW; Nachnani A; Shah S; Briski KP
Asia Pac J Clin Nutr; 2002; 11 Suppl 7():S452-9. PubMed ID: 12492634
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressive effects of tocotrienol in vivo and in vitro.
Wada S; Satomi Y; Murakoshi M; Noguchi N; Yoshikawa T; Nishino H
Cancer Lett; 2005 Nov; 229(2):181-91. PubMed ID: 16098658
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and study of the cancer cell growth inhibitory properties of alpha-, gamma-tocopheryl and gamma-tocotrienyl 2-phenylselenyl succinates.
Vraka PS; Drouza C; Rikkou MP; Odysseos AD; Keramidas AD
Bioorg Med Chem; 2006 Apr; 14(8):2684-96. PubMed ID: 16378730
[TBL] [Abstract][Full Text] [Related]
17. Tocotrienols inhibit growth of ZR-75-1 breast cancer cells.
Nesaretnam K; Dorasamy S; Darbre PD
Int J Food Sci Nutr; 2000; 51 Suppl():S95-103. PubMed ID: 11271861
[TBL] [Abstract][Full Text] [Related]
18. Palm tocotrienols inhibit proliferation of murine mammary cancer cells and induce expression of interleukin-24 mRNA.
Selvaduray KR; Radhakrishnan AK; Kutty MK; Nesaretnam K
J Interferon Cytokine Res; 2010 Dec; 30(12):909-16. PubMed ID: 21121862
[TBL] [Abstract][Full Text] [Related]
19. Optimization of marine triterpene sipholenols as inhibitors of breast cancer migration and invasion.
Foudah AI; Jain S; Busnena BA; El Sayed KA
ChemMedChem; 2013 Mar; 8(3):497-510. PubMed ID: 23404739
[TBL] [Abstract][Full Text] [Related]
20. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
